Imbed Biosciences, a Fitchburg startup whose technology, with tiny silver particles, is used to heal wounds, can start selling its product for use on humans.

The U.S. Food and Drug Administration has cleared Imbed’s Microlyte Ag for prescription and over-the-counter use.

“We are very excited about it,” said Ankit Agarwal, co-founder and CEO, in an interview. Read the full story here.

Read the UW-Madison news release here.